Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00117065
Status:
COMPLETED
Last Update Posted:
2013-04-26
First Post:
2005-06-30
Brief Title:
Study of Transplant Related Anemia Treated With Aranesp STRATA
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
Study of Transplant Related Anemia Treated With Aranesp STRATA
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to evaluate Aranesp administered subcutaneously SC to maintain hemoglobin Hb levels in renal transplant recipients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None